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THE CHEMICAL SYNTHESIS OF AN ENZYME*
BRUCE MERRIFIELD
The Rockefeller University, New York, New York

T

I.

INTRODUCTION

HE complexity of the proteins presents an unparalleled challenge
to the synthetic chemist, and it is only recently that he has been in
a position to respond in a meaningful way. Until now essentially
all that has been learned about this class of compounds has come
from studies on the naturally occurring proteins themselves. The
accumulated body of knowledge is enormous, and very much is
known about the composition and structure of the proteins and
how they function. There are certain questions, however, which
cannot be answered easily in this way and for these questions the
synthetic approach should provide a valuable alternative. If we
could learn how to synthesize proteins in the laboratory it should
become possible to make specific, well defined changes in their
structures which could give answers that are hard to derive from
studies on the native molecules. In certain special cases, such as
the unusually reactive residues at the active sites of enzymes, it
has been possible to modify individual amino acid\ residues selec
tively, but suppose it were to become important to modify or replace
one particular valine residue in the protein; methods simply are not
available to carry out such changes in the presence of many other
similar groups within the same very sensitive macromolecule.
The three-dimensional structure of a small protein, ribonuclease,
is shown in Fig. 1 to illustrate the kind of molecule we are talking
about and to illustrate the magnitude of the synthetic task. This
crystalline molecule (Kunitz, 1940) contains 124 amino acids in a
single polypeptide chain, cross-linked by four disulfide bonds, with
1852 atoms precisely arranged in space in a well defined three
dimensional structure. A chemical synthesis of ribonuclease A means,
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Fm. 1. The three-dimensional structure of bovine pancreatic ribonuclease. Taken
from the model of RNase S by Wyckoff et al. (1967) which was deduced from X-ray
diffraction data at 3.5 A resolution and chemical sequence data. The heavy tubing
outlines the general contours of the polypeptide backbone, and the fine wire structures
show the positions of the amino acid side chains. Reproduced by permission of the
American Society of Biological Chemists, Inc.
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therefore, that each of these atoms must be assembled in the labora
tory into exactly this same sequence and structure. An understanding
of the problem can be greatly simplified, first, by looking at a two
dimensional picture in which the amino acid residues, rather than
the individual atoms, are indicated as the basic units of the structure
(Fig. 2) and, second, by recalling the important hypothesis of
Anfinsen and his associates (White, 1961; Epstein et al., 1962) that
the tertiary structure of this protein is determined by its primary
structure. Thus, there was good reason to believe that if the amino
acids could be assembled into the correct sequence the resulting
molecule would direct its own folding and cross-linking to give the
native protein, and a total synthesis of an enzyme would have been
achieved.
In principle, a protein can be synthesized by either of two general
approaches; by the classical method or by the solid phase method.
The classical method (see Schroder and Liibke, 1965) involves the
preparation of small peptides (fragments), the combination of these
small fragments into larger peptides, and eventually the assembly of
the larger fragments into the final protein molecule. All these
reactions are carried out in homogeneous solution, and the essential
feature of this technique is the opportunity to isolate and purify
the product after each reaction. This helps to ensure high purity
and careful identification of intermediates.
The most dramatic application of the classical technique to the
synthesis of a protein occurred in the period between 1963 and 1965,
with the nearly simultaneous synthesis of insulin by groups in
Germany, the United States, and China (Meienhofer et al., 1963;
Katsoyannis et al., 1964; Kung et al., 1965). At the present time,
syntheses of proinsulin, ribonuclease T1, staphylococcal nuclease,
myoglobin, growth hormone and, no doubt, several other proteins
are under way. As far as I know none of these has been completed,
but two or three can be expected soon. The problems, of course, are
enormous. Large numbers of synthetic reactions and purification
steps are involved, and much time, expense, and manpower is
required.
A variation of the strictly classical method, in which very rapid
Leuchs anhydride couplings were employed, was applied success
fully to the synthesis of S-protein (residues 21-124 of ribonuclease)
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Fm. 2. The two-dimensional structure of bovine pancreatic ribonuclease A, showing the linear, 124 amino acid residue polypeptide chain cross-linked
by the four disulfide bonds. The amino acids are indicated by their three-letter abbreviations. From Smyth et al. (1963), by permission of The American
Society of Biological Chemists, Inc.
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by Hirschmann et al. (1969). This accelerated technique eliminated
the need for isolation of every intermediate, but permitted the
isolation and purification of protected fragments. After noncovalent
binding with·S-peptide (residues 1-20) the resulting ribonuclease S
possessed enzymatic activity.
· The second general approach to the chemical synthesis of proteins
is called solid phase peptide synthesis (Merrifield, 1963, 1969). The
method was devised in our laboratory in an effort to overcome
certain of the difficulties encountered with the classical methods.
It is much faster and simpler to carry out and introduces sizable
savings in manpower and materials. It has made possible our syn
thesis of ribonuclease A (Gutte and Merrifield, 1969, 1971). I would
like to describe this technique in some detail and to discuss some of
the difficulties and problems associated with it as well as some of
the achievements.
II.

Soun PHASE PEPTIDE SYNTHESIS

The basic idea of the solid phase method is outlined in Fig. 3.
It depends on the use of an insoluble solid support. The plan was to
begin with an insoluble particle, indicated by the large circles, to
functionalize it with a group, x, and to attach the first amino acid
of the proposed peptide chain with a stable covalent bond by reaction
at x. In practice we attach at the carboxyl of the amino acid (with
the amino group protected), although in principle the attachment
can also be at the amino group. The amino group is then depro
tected, and the second amino acid is added to the first by a suitable
peptide-forming reaction. In a similar way the subsequent amino
acids are combined in a stepwise manner until the entire sequence
has been assembled. Finally, the bond holding the peptide chain to
the solid support is selectively cleaved, together with most side
chain protecting groups, and the peptide is liberated into solution.
The advantage that I envisioned for this approach was the oppor
tunity to purify intermediates after each reaction by simple, rapid
washing procedures. Since the growing peptide chain would be
completely insoluble as a consequence of its attachment to the large
insoluble support, it could be filtered and washed with large vol
umes of solvents to remove reagents and by-products with no danger
of losing the desired molecule. A related advantage, which was the
real driving force behind the project, was the possibility that the
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COOH

Fm. 3. The basic idea of solid phase peptide synthesis. The large circle represents
the solid support, the small open circles represent amino acid residues, and the dark
circles represent protecting groups and activating groups. From Merrifield, 1971, by
permission of Gordon and Breach, New York.

process could be automated and thereby introduce further efficiency
into the synthesis. It only remained to translate the general idea
into a workable set of reactions.
The support which we have found to be most satisfactory is a
copolymer of styrene and divinylbenzene, containing 1 or 2% of
the cross-linking agent. The resulting beads are illustrated in Fig. 4.
They are about 50 µm in diameter when dry and swell to nearly
8 times their volume in organic solvents such as the halogenated
hydrocarbons. This means that the polystyrene chains are highly
solvated during the chemical reactions and are readily accessible to
diffusing reagents. The reactions occur not only at the surface of
the bead, but, in major part, within the interior matrix of the bead.
This could be readily demonstrated by autoradiography (Merrifield
and Littau, 1968) of cross sections of beads containing a peptide in
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which tritiated praline had been incorporated. The gross distri
bution of peptide chains was quite uniform throughout the sections.
The technique did not, however, have the resolving power to show
the distribution at the molecular level and heterogeneity at that
resolution is probable.
Many detailed chemical schemes have been devised to carry out
solid phase synthesis. An early one which proved to be very useful
is shown in Fig. 5. The aromatic rings of the styrene can be deriva
tized in several ways in order to provide an attachment site for the
first amino acid. The first successful derivative was obtained by

Styrene- diviny I benzene Copolymer

Fm. 4. The styrene-divinylbenzene copolymer support. The spheres average about
50 µm in diameter.
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PEPTIDE

A scheme for solid phase peptide synthesis.

chloromethylation to give a substituted benzyl chloride which could
be esterified by reaction with the triethylammonium salt of an
N"-protected amino acid. The resulting benzyl ester was carefully
chosen because it is quite stable for the remainder of the synthesis
but can be selectively cleaved at the end with strong anhydrous
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acid. In order to be compatible with the anchoring bond the amino
protection should be relatively labile to acid, and the t-butyloxy
carbonyl (Boe) group is commonly employed for that reason. It
can be removed by 1 N HCl or by 20% trifluoroacetic acid in methyl
ene chloride, for example. The resulting amine salt is neutralized by
a tertiary amine, such as triethylamine, and is then ready to couple
to the next Boe-amino acid to form the first peptide bond. Any one
of a number of peptide-forming reagents can be applied. We have
found dicyclohexylcarbodiimide (Sheehan and Hess, 1955) to be
especially useful. Subsequent amino acids are incorporated in exactly
the same way by alternately repeating the deprotection and coupling
reactions. The last step is the cleavage of the peptide from the resin
by acidolysis of the anchoring benzyl ester bond. Hydrogen bromide
in trifluoroacetic acid or hydrogen fluoride (Sakakibara et al., 1967)
are the methods of choice.
Each of the steps described here has been modified in several
ways both in this laboratory and in others (see Marshall and Merri
field, 1971), and certain other changes are still necessary before the
generally applicable, "ideal" system is evolved.
The reaction sequences just described can be illustrated by the
synthesis of bradykinin, which is outlined in Fig. 6 (Merrifield,
1964). Bradykinin is a nonapeptide, derived from a plasma protein,
with strong hypotensive and smooth muscle contracting properties.
The solid phase synthesis began by attaching the protected C-termi
nal amino acid, Boc-nitroarginine, to the polystyrene support and
proceeded by carrying out the three basic steps of deprotection,
neutralization and coupling, alternately, eight times each until the
final peptide sequence was assembled. The peptide was released from
the resin by anhydrous HBr in trifluoroacetic acid, and at the same
time some of the protecting groups were also removed. The re
mainder of the side chain protecting groups, in this case from the
two nitroarginines, were removed by catalytic hydrogenation to
give the crude bradykinin product. Purification by ion exchange
chromatography finally gave analytically pure bradykinin, which
was shown to have full biological activity when compared with
the natural hormone.
Following this early synthesis large numbers of analogs of brady
kinin (Stewart and Woolley, 1966) and several other small peptide
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BRADYKININ

A solid phase synthesis of bradykinin.

hormones, such as angiotensin (Marshall and Merrifield, 1965) and
oxytocin (Manning, 1968), have been synthesized by this same
procedure and by various modifications of it. The method has been
extended to insulin (Marglin and Merrifield, 1966) and to molecules
such as ACTH, parathyroid hormone, secretin, valinomycin, trypsin
inhibitor, several hormone-releasing factors, and a rather sizable
number of model peptides for use in a variety of special problems.
The requirements for a successful synthesis by the solid phase
method are: (1) rapid reactions, (2) quantitative reactions, (3) no
side reactions. We can approach these requirements, but obviously
we do not quite realize them even in the best case. In spite of the
fact that these are heterogeneous reactions, they are very fast (Fig.
7), and there is no real problem in that regard. Some second-order
rate constants for the coupling reaction have been measured which
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indicate that 99% of the reaction between the hindered amino acids
isoleucine and valine required 140 seconds, while the coupling was
99% complete within 10 seconds for most unhindered amino acids.
At the moment the most pressing problem is to devise precise,
sensitive, and rapid methods to monitor the coupling reaction,
because an indication of quantitative bond formation is crucial to
the success of the method. A number of techniques are at hand, but
no one of them meets all the requirements satisfactorily. It is obvi
ously not sufficient to measure the disappearance of the amino acid
reagent because it is present in excess at the outset of the reaction
and precision will only be of the order of a few percent, whereas we
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Fm. 7. A rate curve for the coupling reaction. Coupling reaction: Bpoc-Gly
anhydride (1.6 X 10-2 M) + Val-resin (0.8 X 10-2 M). k2 = 4.0 liters/mole• sec.
Bpoc = biphenylisopropyloxycarbonyl.
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are looking for an accurate measure of the last tenths or even
hundredths of a percent of the reaction. A more sensitive test
is the determination of the amount of unreacted peptide chain, and
several ways to measure the terminal amino group have been de
vised. It can be estimated by the ninhydrin reaction (Kaiser et al.,
1970) or, more quantitatively, by electrometric titration with per
chloric acid (Brunfeldt et al., 1969) or by titration of its hydro
chloride (Dorman, 1969) or picrate salt (Gisin, 1972) or by con
version to a Schiff base and colorimetric assay of the aldehyde com
ponent (Esko et al., 1968).
A second important and continuing effort is directed toward the
identification and elimination of side reactions. Several have been
examined in detail and can now be avoided, while others remain
as special problems. Racemization, for example, has been the uni
versal worry of peptide chemists since the time of Fischer. Loss of
optical purity ·in a biologically active peptide usually will lead to
an inactive molecule, and in all cases it will result in a diastereomeric
mixture which is exceedingly difficult to purify. This area has
received a great deal of attention, and both conventional and solid
phase syntheses can be designed which result in a negligible degree
of racemization. It is a remarkably fortunate circumstance that the
urethane protecting groups for amino acids, which are am-6ng the
best derivatives for synthetic reasons, also confer high resistance to
racemization. The accumulated evidence from many syntheses con
firms the belief that there is essentially no racemization by way of
oxazolone intermediates in solid phase syntheses. It was discovered
recently, however, that urethane-protected histidine derivatives can
give rise to appreciable amounts of racemic products both by con
ventional couplings in solution and by solid phase couplings (Wind
ridge and Jorgensen, 1971). The reaction probably proceeds by
direct proton abstraction from the asymmetric a-carbon by the basic
imidazole group, because the presence of an electron withdrawing
substituent (dinitrophenyl) on the imidazole ring greatly reduced
the effect. Work in our laboratory confirms their findings and shows
that a p-toluene sulfonyl substituent on histidine essentially elimi
nates the racemization problem (Lin et al., 1972).
Dr. Gisin has recently discovered another side reaction during a
solid phase synthesis and, by studying its mechanism, has devised a
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way to eliminate it (Gisin and Merrifield, 1972). During the prepa
ration of Boc-n-Pro-n-Val-L-Pro-resin it was observed that over
70% of the peptide had been lost from the resin. By examining each
of the steps in the synthesis, it was found that the loss occurred
during tht= customary 10-minute equilibration treatment of n-Val-L
Pro-resin with Boc-n-Val prior to addition of the coupling reagent. It was then shown that the product was n-Val-L-Pro-diketopipera
zine and that its formation was strongly catalyzed by carboxylic
acids-in this case by Boc-n-Pro (Fig. 8). Imino acid-containing
dipeptides, such as those containing praline or N-methylalanine,
are especially susceptible to the diketopiperazine formation because
of the small energy difference between the cis and tt;ans amide con
formations. Once the problem was understood, a simple solution
was forthcoming; the order of addition of reagents was reversed,
the presence of free carboxylic acid was eliminated, and the catalysis
of the ring closure was avoided. With this improvement Gisin has
gone on to complete the stepwise solid phase synthesis of the very
interesting valinomycin analog -[L-Val-n-Pro-n-Val-L-Pro]a-. This
H-o-Vol-L-Pro-0-resin
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Fm. 8. The proposed mechanism for the acid-catalyzed formation of a diketo
. piperazine. From Gisen and Merrifield (1972), by permission of the American Chemical
Society, Washington, D.C.
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is the first cyclic peptide composed entirely of amino acids that can
selectively bind potassium and carry it from an aqueous solution
into a hydrophobic organic phase.
Because the solid phase method in its usual form does not allow
isolation of intermediates, some people feel that it can never be
applied to the synthesis of high molecular weight products. I believe
that it can be utilized for such problems at the present time and
that, through the improvements which are constantly being made,
the continuous, stepwise approach will eventually be the method of
choice. For those who prefer to isolate protected intermediates, we
have devised a new solid phase-fragment approach (Wang and
Merrifield, 1969) in which small protected peptides are prepared on
a resin support and, following cleavage and purification, are coupled
in solution to give larger peptides. This technique, therefore, com
bines some of the best features of the solid phase and classical ap
proaches into a unified procedure. In its initial and usual form, as
already described here, the solid phase method produces partially
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Fm. 9. A solid phase-fragment scheme. From Wang and Merrifield (1972), by
permission of Munksgaard, Copenhagen.
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or completely deprotected peptides following the cleavage step in
strong acid. These products, of course, are not suited for further
couplings because they contain functional side chains. To overcome
the problem, three classes of protecting groups are needed which
can be selectively removed, as illustrated in Fig. 9. The group on
the a-amine must be readily removed at each step of the synthesis
without loss of side chain protection or of the anchoring bond to
the resin, and at the end of the synthesis it must be possible to cleave
the anchoring bond without loss of side chain protection. Finally,
after the intermediate protected peptide has been purified and coupled
to other fragments it must be possible to completely deprotect the
finished polypeptide. The scheme developed by Dr. Wang makes use
of three greatly different degrees of acid stability. He uses the very
labile biphenylisopropyloxycarbonyl (Bpoc) group of Sieber and
Iselin (1968) for a-amine protection, relatively stable benzyl or tosyl
groups for side chain protection, and a new linkage of intermediate
stability for the carboxyl attachment. These groups differ by 3 and
6 orders of magnitude in their susceptibility to acid and, therefore,
allow the satisfactory synthesis of protected fragments. A recent
synthesis of an eledoisin analog will illustrate this general approach
(Wang and Merrifield, 1972). The analog
CH3
_____/0\
Z-Lyx(Z)-Phe-Phe-Gly-0-�-CH2-CH2---VResin
CH3

was synthesized using Bpoc derivatives for the intermediate coupling
steps and carbobenzoxy protection for the last step. The protected
peptide was removed by 50% trifluoroacetic acid and was obtained
as a pure crystalline product. It was coupled in solution with
H-Leu-Met-OMe, crystallized, aminolyzed and finally deprotected
to give H-Lys-Phe-Phe-Gly-Leu-Met-NH2 • The pure product showed
the expected strong hypotensive action in the rat, which was equal
to that of natural eledoisin itself.
Until now I have not discussed the mechanical aspects of this
technique except to say that it was because of this potential feature
that the solid phase method was developed in the first place. The
ability to purify by simple filtration and washing and the fact that
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all reactions could be conducted within a single reaction vessel
appeared to lend themselves ideally to a mechanized and automated
process. Initially, a simple manually operated apparatus was con
structed (Fig. 10), and later, together with Dr. Stewart, we designed
and built the automated instrument shown in Fig. 11 (Merrifield
et al., 1966). The essential features were the reaction vessel contain
ing the resin with its growing peptide chain and the necessary
plumbing to enable the appropriate solvents and reagents to be
pumped in, mixed, and removed in the proper sequence. The me
chanical events were under the control of a simple stepping drum
programmer and a set of timers. This instrument has been used for
the synthesis of many small peptides and for the synthesis of ribo
nuclease A. In the past few years at least nine commercial instru
ments have been constructed in several countries. They differ con
siderably in detail, but are designed to carry out the same chemistry.

Fm. 10. A manually operated reaction apparatus, showing the glass reaction
vessel with a fritted-glass filter disk and side arm. The resin is suspended by a rocking
motion about the horizontal axis.

159

CHEMICAL SYNTHESIS OF AN ENZYME

Fm. 11. The automated peptide synthesizer.

III.

THE SYNTHESIS OF RrnoNUCLEASE

A

As a first step toward bringing to bear the synthetic approach to
the study of enzymes we undertook the total synthesis of bovine
pancreatic ribonuclease A (Gutte and Merrifield, 1969, 1971). This
molecule, which has been so closely associated with this institution,
was well suited for the synthetic work because it is small and
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Fm. 12. Protected ribonuclease A.
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stable and its amino acid sequence (Hirs et al., 1960; Smyth et al.,
1963) and X-ray crystallographic structure were known (Kartha
et al., 1967; Wyckoff et al., 1967, 1970).
The formula in Fig. 12 shows the protected derivative of ribo
nuclease which we wished to synthesize. It contains a total of 67
side chain protecting groups, largely based on benzyl derivatives for
stability, and has a molecular weight of 19,791. The synthesis
carried out by Dr. Gutte followed essentially the same procedure
as that outlined in Fig. 5, while the workup, identification, and
analysis of the product utilized a variety of techniques. The synthe
sis, which has already been described in complete detail (Gutte and
Merrifield, 1971), is summarized in Table I. It shows that the
overall yield was about 3%, i.e., of the first amino acid, valine,
originally attached to the resin 3% was eventually recovered in the
TABLE I
RIBONUCLEASE A SYNTHESIS

Overall yield

Stage of synthesis

Mg

Boe-Val-Resin
lkprntect
l Neutralize j Repeat 123 times
Couple
1 7%
Protected RNase-Resin
Cleave =d · deprntect
HF
71%
Crude RNase (SH)s
Sephadex G-75
t
53 %
RNase A (monomer fraction)
69 % Trypsin digestion
i
Sephadex G-50
RNase A (Trypsin resistant fraction)
66% tCNH4)2S04 fractionation
RNase A

2000

100

3430

17

697

12

I

i

%

373

6.4

256

4.4

169

2.9
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final purified protein. A large accumulated loss occurred during the
synthesis itself. This means that the benzyl ester bond anchoring
the peptide to the resin was not entirely stable to the repeated
acidic conditions of the synthesis and was lost to the extent of
about 1.4% at each cycle. I must emphasize that this has nothing
to do with the individual coupling yields, which we believe were
high. The cleavage step and the numerous workup steps taken
together accounted for another 80% loss of material. The quantities
of ribonuclease indicated in Table I are the calculated amounts of
product that would have been obtained if all the material had
been carried through all these steps. During this work the material
was divided into many fractions in order to work out the best
procedures and to obtain analytical samples, so that the most ribo
nuclease available at any time was of the order of 25 mg. When
the crude HF-cleaved protein was oxidized and fractionated on an
IRC-50 column in phosphate buffer it showed a large peak containing
the enzymatic activity and two small· inactive peaks. The specific
activity could not be raised above 13% by recycling through this
column. We then decided to take advantage of the known stability
of ribonuclease A to trypsin digestion (Dubas and Thompson, 1938).
The reasoning was that material with the correct structure would
come through the treatment intact, while molecules with incorrect
structures due to incomplete sequences or improper folding would
give rise to a mixture of small molecules that could readily be
separated from the native molecule (Fig. 13). To our great satis
faction the activity of a crude sample treated in this way increased
from 8% to 61%, while only 25% of the protein was actually
removed. A further purification step involved an ammonium sulfate
fractionation in which some amorphous material could be separated,
and a lyophilized preparation possessing nearly 80% specific activity
was finally obtained. Table II summarizes the activity data obtained
at various stages of purification of the synthetic enzyme. It also
shows how the total number of units of RNase activity increased
as the purification proceeded.
We interpret these data to mean that inhibitory peptides were
present which were giving rise to low enzyme activity val�es and
the crude preparation actually contained more enzyme than we had
thought. The purified RNase A was then placed on a CM-cellulose
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+
Incorrect structures

Native conformation

t Trypsin

+
Small peptides

RNase A
Fm. 13.
digestion.

Schematic view of the purification of synthetic ribonuclease A by trypsin

column and compared with natural RNase A and reduced-reoxidized
natural RNase A. They were identical by this criterion, which was
the one first used by White (1961) to show that RNase A after
reduction and reoxidation was indistinguishable from native RNase.
His was the demonstration that led to the hypothesis that the
primary structure of the protein determined its tertiary structure.
Our synthesis provides a new kind of evidence for this hypothesis.
The fact that the only information put into the synthesis was the
linear sequence means that the primary structure must be sufficient
TABLE II
RrnoNUCLEASE

Purification stage
HF cleavage
Sephadex G-75
IRC-50
Trypsin
(NH4)2S04

A Acnv1TY

Total activity
Specific
activity (mg RNase/2 gm
resin)
(%)
2
9

13
61

78

14
33
53
156
132

164

BRUCE MERRIFIELD

TABLE III
EVIDENCE FOR PURITY AND IDENTITY OF SYNTHETIC RNASE A

Technique

Conclusion

Gel filtration
Ion-exchange chromatography
Paper electrophoresis
Amino acid analysis
Digested by papain
APM
Resistant to trypsin digestion
Fingerprint of tryptic digest of
oxidized RNase
8. Neutralization of antibody
9. Enzymatic assay

Similar molecular size
Similar net charge
Similar charge and size
Similar amino acid compositiop
No major racemization
Compact folding
Similar amino acid sequence

1.
2.
3.
4.
5.
6.
7.

+

Similar antigenic determinants
High specific activity and similar
substrate specificity

to direct the final folding of the molecule into its active tertiary
structure. By starting with free amino acids any objections to the
original experiments based on retention of some residual confor
mation after the reduction step which might serve to initiate the
refolding are eliminated. The synthesis of an active enzyme con
taining no substituents except amino acids also provides a new
proof for the now well-established belief that enzymatic activity
can be a consequence of a simple protein and that no other com
ponents either known or unknown need be present. Not too many
years ago such a view was vehemently opposed.
What we cannot claim is that this synthesis constitutes a proof
of structure for ribonuclease A. Such a proof in the classical organic
chemistry sense wiU be very difficult indeed because it is virtually
impossible with present methods to establish absolute identity be
tween two macromolecules of such complexity.
The various kinds of evidence that have been obtained to establish
the identity and purity of the synthetic RNase A are listed in Table
III. Clearly, each of these tests has limitations and we can only say
that within these limits the synthetic preparation closely resembles
native ribonuclease A in its chemical and physical properties, that
it has a high specific activity and that it shows the expected sub
strate specificity.
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STRUCTURE FUNCTION STUDIES

As I indicated earlier, one of the prime objectives of synthetic
work on proteins is to develop the methods and capability to
investigate various questions that are not easy to examine by studies
of the naturally occurring proteins themselves. The synthesis of
ribonuclease A has provided answers to some rather fundamental
questions, and we feel that it has laid a foundation for new studies
on structure-function relations in enzymes. As a bare beginning, I
would like to discuss two such studies.
In considering the well known S-peptide/S-protein system dis
covered by Richards (1955, 1958), in which these two inactive
components can recombine noncovalently to produce a fully active
enzyme, we wondered whether the recombination would occur if
the protein component were shortened at its amino terminus by the
removal of residues 21 through 25, and whether the complex would
be enzymatically active. To test this question a sample of peptide
resin containing residues 25-124 was removed during the RNase
synthesis, and another containing residues 21-124 was removed
after the addition of 5 more residues (Fig. 14). These two synthetic
proteins, corresponding to des-21-25 S-protein and to S-protein,
Ribonucleose S
pt_id_e____
_____s_-...:.p_e ;_

J1�-0H

1 Lys
I
H

40
S-prote1n

Fm. 14. The S-peptide, S-protein, des 21-25 S-protein system. From Gutte and
Merrifield (1970), by permission of The American Society of Biological Chemists, Inc.
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were partially purified on Sephadex and then reduced at their 4
disulfide bonds. The resulting random coils were mixed with S-pep
tide (natural or synthetic), reoxidized and assayed for enzyme
activity. The crude mixtures were both found to have approxi
mately 25% as much activity as the product derived from native
S-protein by the same treatment. From these data we can say,
qualitatively, that the first five residues, 21-25, are definitely not
necessary for the binding and reactivation to occur and, quanti
tatively, that there is probably no appreciable effect whether they
are present or absent. Wyckoff and Richards had already predicted
from their X-ray data that the three serines at positions 21, 22, and
23 would probably not be necessary since there was no indication
of noncovalent interactions with other residues in the crystal. In
contrast, asparagine 24 and tyrosine 25 appeared to be involved in
a total of 5 hydrogen bonds, and it was reasonable to expect that
they would be important in stabilizing the complex between S-pep
tide and S-protein and might be necessary for the formation of an
active complex. Our data indicate that those bonds are not required
either for binding or activity.
About 5 years ago I became interested in the question of whether
or not i peptide component from the carboxyl end of ribonuclease
might function in a manner analogous to that of S-peptide at the
amino end. This was a good problem for synthesis because there
was no enzyme available to make the necessary cleavage in the
vicinity of residue 111. Consequently, Dr. Gutte synthesized the
RNase 111-124 tetradecapeptide, H-Glu-Gly-Asn-Pro-Tyr-Val-Pro
Val-His-Phe-Asp-Ala-Ser-Val-OH, and obtained it in a high state
of purity. To test its ability to bind and activate an inactive protein
component he prepared N 1-carboxymethyl histidine-119-RNase.
Many attempts to reactivate this protein by addition of the peptide
met with uniform failure. It appeared that the peptide was unable
to displace the tail of the protein and to bind in its place in a way
that would place His 119 in a proper position to function catalytically.
The problem was set aside while the work on the total synthesis of
RNase proceeded, but was resumed about two years later when
Lin et al. (1968) succeeded in preparing a series of shortened RNases.
They made RN ase 1-120 by peptic digestion and RN ase 1-119 and
RNase 1-118 by further digestions with carboxypeptidase A. When
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Fm. 15. Enzymatic activity of the synthetic RNase 111-124 tetradecapeptide with
shortened ribonucleases. From Lin et al. (1970), by permission of The American Society
of Biological Chemists, Inc.

the synthetic peptide 111-124 was assayed in the presence of these
inactive proteins, high enzymatic activity was regenerated (Fig. 15).
Through a joint effort with Lin, Moore, Gutte, and Caldi, we have
studied the combination of a number of carboxyl-terminal peptides
with the shortened protein components and have been able to
answer a number of interesting questions (Lin et al., 1970, 1972;
Gutte et al., 1972). These experiments can be discussed best by
referring to Fig. 16. This shows how we visualize the peptide in
serting itself into the three-dimensional structure of the protein to
produce an active enzyme. As can be seen there are 8-10 overlapping
residues between the two components, and we naturally wondered
how long a peptide was actually required to produce the effect. A
series of C-terminal peptides was therefore synthesized and tested
in the presence of RNase 1-118 (Table IV). With peptides containing
7 or 8 residues there was very little activity, but the addition of
Val116 made a dramatic increase to 60%. Further lengthening of the
chain increased the binding gradually to a maximum of 98%. The
role of Val 116 is now being examined in more detail to try to de-
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Fm. 16. Schematic representation of peptide-protein complexes in reconstituted
ribonuclease. The drawing is based on the X-ray structure of RNase A by Kartha
et al. (1967).
TABLE IV
EFFECT OF CHAIN LENGTH oN

RN ASE 1-118
Chain
length

7
8
9
10
11
12
14

AcnvATION

OF

WITH COOH-TERMINAL PEPTIDES

Peptide sequence

Activitya
(%)

Val-His-Phe-Asp-Ala-Ser-Val
Pro-Val-His-Phe-Asp-Ala-Ser-Val
Val-Pro-Val-His-Phe-Asp-Ala-Ser-Val
Tyr-Val-Pro-Val-His-Phe-Asp-Ala-Ser-Val
Pro-Tyr-Val-Pro-Val-His-Phe-Asp-Ala-Ser-Val
Asn-Pro-Tyr-Val-Pro-Val-His-Phe-Asp-Ala-Ser-Val
Glu-Gly-Asn-Pro-Tyr-Val-Pro-Val-His-Phe-Asp-Ala-Ser-Val

1
1.5
60
70
80
90
98

a Maximum activity, in presence of excess peptide, relative to an equimolar amount
of native RNase A. From Gutte et al. (1972), by permission of the Amerian Society
of Biological Chemists, Inc.
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termine whether it is simply a matter of peptide length or whether
there is a unique function for valine itself.
Notice that in the combination of peptide 111-124 with protein
1-119 or protein 1-120 there is a His119 in both components. Since
His119 is known to be involved in the catalytic mechanism of ribo
nuclease (Crestfield et al., 1963) the question arose as to which of
these residues was participating in the reconstituted complexes.
Evidence was obtained by examining the alkylation pattern of the
complexes after treatment with iodoacetate (Table V). Native ribo
nuclease alkylates either at His1 2 or His119 , in a ratio of about 1 to 7,
and the extent of alkylation correlates with the enzymatic activity
of various derivatives of RNase; thus RNase 1-120 has very low
activity and is poorly alkylated while RNase 1-119 is inactive and
is not alkylated under these conditions. It was found that the com
plex between peptide 111-124 and RNase 1-120 was alkylated at
His119 of the protein component and also at His 119 of the peptide in
a ratio of about 1 to 4, and the complex between peptide 111-124
TABLE V
ALKYLATION OF HISTIDINE RESIDUES IN THE RECONSTITUTED COMPLEXES

Site of alkylation
Components
Protein

Peptide

RNase 1-124 (native RNase A)
RNase 1-120
RNase 1-119
RNase 1-120 + RNase 111-114
RNase 1-119 + RNase 111-124
RNase 1-118 + RNase 111-124
RNase 1-118 + [Ile 120]RNase 111-124

His 1 19

His12
Protein

Protein

0.12
0.20
0
0.14
0.10
0.10
0.10

0.77
0.06
0
0.24
0.50

Peptide

0.06
0.40
0.70
0.07

a Determined by measurement of the number of moles of N 3-His(Cm)
or N 1-His(Cm) per mole of protein. The N 3-His(Cm) is assumed to occur
only at His12 of the protein and N 1-His(Cm) only at His 119 of the protein
or peptide. From Gutte et al. (1972), by permission of The American
Society of Biological Chemists, Inc.
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and RNase 1-119 alkylated to nearly the same extent in both com
ponents. We interpret this to mean that these complexes exist in at
least two conformations in which the peptide His119 is functioning
catalytically part of the time and the protein His 119 is functioning
part of the time. Since dissociation constants could be measured,
the two conformational forms must be in equilibrium with one
another. In the case of peptide 111-124 and protein 1-118 there is
only one His119 , and all of the alkylation occurred in the protein.
A third question which we have studied by synthesis concerns
the -role of Phe 120 . This residue is known to stabilize ribonuclease
and was expected to be involved in binding_ the synthetic peptides to
the shortened RNase molecules. There is also evidence from X-ray
and nuclear magnetic resonance studies that Phe 120 is located very
close to the pyrimidine ring of the substrate and may be involved
in binding substrate to RNase. We have obtained evidence on these
points by synthesizing replacement analogs and combining them
with RNase 1-118, (Table VI). Phe 120 in the peptide 111-124 was
replaced by the hydrophobic but nonaromatic residues leucine and
isoleucine and by the large aromatic residue tryptophan. It was
found that the dissociation constant, Kd, increased by a factor of 12
when Leu 1 20 was present, by 20 when Ile 120 was present, and by
TABLE VI
EFFECT OF PHE REPLACEMENTS ON THE DISSOCIATION CONSTANT OF THE
PEPTIDE-PROTEIN COMPLEXES AND ON THE MICHAELIS CONSTANT AND
INHIBITOR DISSOCIATION CoNSTANT a
120

Km
Kd

Components of the complex
RNase A
[Phe 120]RNase 111-124 + RNase 1-118
[Leu 120JRNase 111-124 + RNase 1-118
[Ile 1 20]RNase 111-124 + RNase 1-118
[Trp 120JRNase 111-124 + RNase 1-118

(M)

2.0 X
2.5 X
4.0 X
3.5 X

for C > p

(M)

0.7 X
10- 7 0.7 X
10- s 1.0 X
10- s 1.2 X
10-s

K;

for 2' Cp

(M)

10-3 0.9 X 10-s
10 - 3
10-3
10- 3 1.1 X 10 -5

a From Lin et al. (1972), by permission of The American Society of Bio
logical Chemists, Inc.
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170 when Trp120 was present, suggesting a failure to fit properly
into the hydrophobic pocket normally occupied by Phe 120 • Further
more, even when the peptide was present in saturating concentra
tions, full enzymatic activity could not be regenerated by these
peptide analogs. It therefore appears that phenylalanine plays a
very important role in binding the carboxyl end of ribonuclease to
the remainder of the protein and in properly aligning the catalytic
site.
To obtain information about the role of Phe 120 in binding sub
strate, the Michaelis constant, Km, for 2', 3'-cyclic cytidylic acid
and the substrate inhibition constant, Ki, for 2'-cytidylic acid were
examined. These values are related to the strength of binding
of substrate to the enzyme complex. Within the experimental error,
Km, was essentially the same for native RNase and for the complexes
containing Phe, Leu, or Ile at position 120, indicating that phenyl
alanine had no unique role in binding substrate, and that if it played
any part in the binding its role could be equally well assumed by
leucine or isoleucine. A similar conclusion could be reached from
the inhibition constant for 2'-cytidylic acid which was nearly the
same whether Phe 120 or Ile 120 was present.
The final experiment I would like to mention concerns the as
sembly of a three-component enzyme (Fig. 16). We discovered that
S-peptide (1-20), containing His12 , and the C-terminal peptide
(111-124), containing His119, could be mixed in solution with RNase
(21-118), containing Lys41 , and that they would bind noncovalently
to produce a complex possessing about 30% specific activity. Thus,
three separate peptides, each containing one of the amino acids
known to function in the catalytic mechanism of ribonuclease,
could reassociate in a very specific way to reconstitute the catalytic
site and the substrate binding site and produce the active enzyme.
V.

CONCLUSIONS

I have described a new approach to peptide synthesis, called
solid phase peptide synthesis, and have indicated some of its virtues
and some of the disadvantages and problems associated with it. The
application of this technique to the synthesis of small peptides was
described, and its use in the first total synthesis of an enzyme was
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discussed. Finally, some examples were presented to show how the
synthetic approach can be used to answer questions about the
structure and function of proteins.
It is now possible to synthesize true proteins with real enzymatic
activity beginning with simple amino acids. I believe that in the
years ahead we will see a great deal of progress in this area which
will contribute in a significant way to our understanding of this
very important class of compounds.
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